Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 4
2006 11
2007 8
2008 17
2009 29
2010 22
2011 20
2012 23
2013 21
2014 13
2015 11
2016 12
2017 23
2018 23
2019 6
2020 14
2021 31
2022 19
2023 20
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

278 results

Results by year

Filters applied: . Clear all
Page 1
von Willebrand factor/factor VIII concentrate (Wilate) prophylaxis in children and adults with von Willebrand disease.
Sidonio RF Jr, Boban A, Dubey L, Inati A, Kiss C, Boda Z, Lissitchkov T, Nemes L, Novik D, Peteva E, Taher AT, Timofeeva MA, Vilchevska KV, Vdovin V, Werner S, Knaub S, Djambas Khayat C. Sidonio RF Jr, et al. Among authors: taher at. Blood Adv. 2024 Mar 26;8(6):1405-1414. doi: 10.1182/bloodadvances.2023011742. Blood Adv. 2024. PMID: 38237075 Free PMC article.
Αlpha-thalassemia: A practical overview.
Musallam KM, Cappellini MD, Coates TD, Kuo KHM, Al-Samkari H, Sheth S, Viprakasit V, Taher AT. Musallam KM, et al. Among authors: taher at. Blood Rev. 2024 Mar;64:101165. doi: 10.1016/j.blre.2023.101165. Epub 2024 Jan 3. Blood Rev. 2024. PMID: 38182489 Free article. Review.
Compliance and clinical benefit of deferasirox granule and dispersible tablet formulation in pediatric patients with transfusional iron overload: in a randomized, open-label, multicenter, phase II study.
Taher AT, Wali Y, Cruz MC, Charoenkwan P, Aydinok Y, Werner O, Govindaraju S, Romen F, Viprakasit V. Taher AT, et al. Haematologica. 2024 May 1;109(5):1413-1425. doi: 10.3324/haematol.2023.283133. Haematologica. 2024. PMID: 37855069 Free article. Clinical Trial.
Luspatercept for transfusion-dependent β-thalassemia: time to get real.
Musallam KM, Sheth S, Cappellini MD, Kattamis A, Kuo KHM, Taher AT. Musallam KM, et al. Among authors: taher at. Ther Adv Hematol. 2023 Aug 26;14:20406207231195594. doi: 10.1177/20406207231195594. eCollection 2023. Ther Adv Hematol. 2023. PMID: 37645382 Free PMC article. No abstract available.
Beta-thalassemia: is cure still a dream?
Hodroj MH, Akiki N, Bou-Fakhredin R, Taher AT. Hodroj MH, et al. Among authors: taher at. Minerva Med. 2023 Dec;114(6):850-860. doi: 10.23736/S0026-4806.23.08501-4. Epub 2023 Aug 3. Minerva Med. 2023. PMID: 37534831 Review.
How I treat non-transfusion-dependent β-thalassemia.
Saliba AN, Musallam KM, Taher AT. Saliba AN, et al. Among authors: taher at. Blood. 2023 Sep 14;142(11):949-960. doi: 10.1182/blood.2023020683. Blood. 2023. PMID: 37478396 Free PMC article.
278 results